topotecan has been researched along with Dyspnea in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahams, C; Caligiuri, P; Desai, AA; Hogarth, DK; Maitland, ML; Salgia, R; Wilcox, R | 1 |
1 other study(ies) available for topotecan and Dyspnea
| Article | Year |
|---|---|
Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Dyspnea; Fatal Outcome; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Pulmonary Alveoli; Pulmonary Fibrosis; Respiratory Insufficiency; Topotecan | 2006 |